Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-330P encodes a pseudogene that is homologous to the functional U6 snRNA, a small nuclear RNA component essential for pre-mRNA splicing in the spliceosome[1][3][9]. As a pseudogene, RNU6-330P is not believed to produce a functional RNA product. U6 snRNA pseudogenes generally arise via retrotransposition (processed pseudogenes) or gene duplication (unprocessed pseudogenes)[2][4]. While most pseudogenes, including RNU6-330P, are not transcribed or functional, some may participate in gene regulation through RNA interference pathways or by acting as decoys for regulatory molecules in specific contexts, but there is no evidence for such a role for RNU6-330P itself[2][4][5]. This gene is not considered a therapeutic or pharmacological target. Like other non-coding RNA pseudogenes, its principal relevance in research is as a genomic relic, though in rare cases some pseudogenes have been co-opted for regulatory functions or can be transcribed as non-coding RNAs[2][4][5]. There are no drugs, mechanisms of action, biomarkers, or safety concerns directly associated with RNU6-330P.
None known for direct targeting; not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 330, pseudogene (RNU6-330P).